Who has invested in Trillium Therapeutics?

Pfizer are named among the investors backing Trillium Therapeutics.

Trillium Therapeutics Funding: $2.3B Raised, IPO (2021)

Trillium Therapeutics funding overview

Trillium Therapeutics has raised $2.3B in total disclosed funding. That places its disclosed total in over $1B. Its most recent disclosed round is an IPO announced in August 2021. The round record for Trillium Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Pfizer.

Trillium Therapeutics at a glance

Total raised: $2.3B
Latest round: IPO
Latest round date: August 2021
Notable investors: Pfizer

Frequently asked about Trillium Therapeutics funding

How much has Trillium Therapeutics raised?: Trillium Therapeutics has raised $2.3B in total disclosed funding across the rounds on record.
Who has invested in Trillium Therapeutics?: Pfizer are named among the investors backing Trillium Therapeutics.
What was the latest Trillium Therapeutics funding round?: The most recent disclosed round is an IPO, announced in August 2021.
Where is Trillium Therapeutics based?: No headquarters location is disclosed for Trillium Therapeutics.
When did Trillium Therapeutics last raise?: The last disclosed Trillium Therapeutics round closed in August 2021 at IPO.

Trillium Therapeutics totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies below to benchmark round size and investor mix.

Trillium Therapeutics Funding: $2.3B Raised, IPO (2021)

Trillium Therapeutics funding overview

Trillium Therapeutics at a glance

Frequently asked about Trillium Therapeutics funding

Companies related to Trillium Therapeutics (12)

Browse related funding lists (4)